Tag: HVAD

Targeted blood pressure management helps to reduce strokes in patients with...

An analysis on the impact of stroke severity in patients receiving the HeartWare HVAD system (Medtronic) as destination therapy shows that targeted blood pressure...

HeartWare HVAD system receives US FDA approval

Medtronic has received United States Food and Drug Administration (FDA) approval for a less-invasive implant approach of its HVAD System, a left ventricular assist...

FDA classifies HeartWare HVAD systems unexpected power source switching as Class...

The United States Food and Drug Administration (FDA) has classified Medtronic recent voluntary urgent field action related to the HeartWare HVAD System unexpected power...

Medtronic HeartWare HVAD approved for destination therapy

The US Food and Drug Administration (FDA) has approved Medtronic’s HeartWare HVAD system as a destination therapy for patients with advanced heart failure who...

Medtronic ENDURANCE Supplemental trial of HVAD fails to meet primary endpoint

Medtronic’s ENDURANCE Supplemental trial of the company’s HVAD ventricular assist device has failed to meet its primary endpoint of all neurological events at 12...

Medtronic receives CE mark for less-invasive HVAD implant procedure

Medtronic’s HVAD system left ventricular assist device (LVAD) has received CE mark for a less-invasive implant procedure in patients with advanced heart failure. The...